TITLE

DNA Folly Continues

AUTHOR(S)
Watson, James D.
PUB. DATE
January 1979
SOURCE
New Republic;1/13/79, Vol. 180 Issue 2, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Comments on the debate over conducting recombinant DNA research and examines the reasons behind the highly cautious approach adopted towards recombinant DNA research and development in the scientific community and among the general public. Alleged threat of recombinant DNA research to civilization; Benefits offered by the technology; Reasons given for opposing the use of the technology; Impact of a temporary moratorium on experiments in 1974; Guidelines issued by the U.S. National Institutes of Health.
ACCESSION #
11102160

 

Related Articles

  • NIH Proposes "Loosening" Recombinant DNA Guidelines. N. K. E. // BioScience;Sep1978, Vol. 29 Issue 9, p560 

    The article reports that the U.S. National Institutes of Health (NIH) has proposed revised guidelines for recombinant DNresearch. NIH Director Donald Fredrickson stated that the changes are designed to correct the chilling inflexibility of the original guidelines, issued in June 1976. NIH has...

  • The Cambridge Experimentation Review Board.  // Bulletin of the Atomic Scientists;May1977, Vol. 33 Issue 5, p22 

    The article highlights the report by the Cambridge Experimentation Review Board on the use of the recombinant DNA technology in the city of Cambridge, Massachusetts. The board shall consider whether research on recombinant DNA, which is proposed to be conducted at the P3 level of physical...

  • The Importance, and Promise, of Recombinant DNA Research. Reel, Jeffrey // Macrobiotics Today;Mar/Apr2005, Vol. 45 Issue 2, p39 

    Shares the author's insights on the utilization of recombinant DNA for the production of genetically modified organisms. Research on genetically altered mice; Combination of the DNA of a blackfly with the DNA of the Eastern Canadian Goose; Implications of recombinant DNA research.

  • Office of Biotechnology Activities; Recombinant DNA Research: Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). Tabak, Lawrence A. // Federal Register (National Archives & Records Service, Office of;2/21/2013, Vol. 78 Issue 35, p12074 

    This article presents a notice of changes to the National Institutes of Health guidelines for research involving recombinant DNA molecules.

  • The RAC: Double, Double, Toil, and Trouble? Ertl, Hildegund // Molecular Therapy;Mar2009, Vol. 17 Issue 3, p397 

    The article discusses the objective of the Recombinant DNA Advisory Committee (RAC), which is to ensure clinical trials on recombinant DNA (rDNA) research and gene transfer. The author says that the committee has developed and has been involved in revisions to the National Institutes of Health...

  • Office of Biotechnology Activities; Recombinant DNA Research: Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). Corrigan-Curay, Jacqueline // Federal Register (National Archives & Records Service, Office of;10/11/2011, Vol. 76 Issue 196, p62816 

    The article offers information on the move of the Office of Biotechnology Activities (OBA) to update the U.S. National Institutes of Health (NIH) Guidelines' Appendix B. It states that OBA aims to specify the risk group (RG) classification for several common attenuated strains of bacteria and...

  • Senate Hears Proposals for Regulation Without Legislation. Leeper, E. M. // BioScience;Dec1977, Vol. 27 Issue 12, p775 

    The article reports on the hearing of the U.S. Senate Subcommittee on Science, Technology and Space on recombinant DNA. Subcommittee chairman Adlai E. Stevenson says that a fresh appraisal from the committee will clear the air on the issue. The committee thinks that new insights have come to the...

  • The Road to Reauthorization for NIH. Feller, Claudia // BioScience;Nov1983, Vol. 33 Issue 10, p621 

    The article discusses the Public Health Service Act of the U.S. which is meant to reauthorize the funding flexibility of the National Institutes of Health (NIH). The funding flexibility of the NIH is known as Section 301 authority under the act. The act is scheduled for reauthorization during...

  • Recombinant DNA: The Debate Goes On. Sullivan, Daniel J. // America;11/10/1979, Vol. 141 Issue 14, p280 

    The article focuses on the decision for the future of recombinant DNA research, which will be made by Dr. Donald Frederickson, director of the National Institute of Health in the U.S. His responsibilities for promoting medical research while protecting the public put him in an important but...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics